Global report - August 22, 2025
EU, US trade statement: 15% tariffs on pharmaceuticals
The joint statement, released yesterday, confirms that cars, semiconductors, and pharmaceuticals will face a maximum 15% tariffs to enter the US.
Global report - August 6, 2025
USA: USD 500 million in funding for mRNA vaccine contracts canceled
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced the cancellation of contracts and grants earmarked for the development of mRNA vaccines.
Collaboration - July 30, 2025
The new European Life Science Strategy has been launched
Earlier this summer, the European Commission launched a new strategy to make Europe the most attractive place in the world for life sciences by 2030.
Global report - July 28, 2025
AstraZeneca plans to invest USD 50 billion in US manufacturing and R&D
This investment is expected to create tens of thousands of new jobs across the country states the company.
Global report - June 13, 2025
AstraZeneca enters collaboration with CSPC Pharmaceuticals
AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group Limited.
Global report - June 9, 2025
Lif: “The Council of Ministers’ compromise weakens the EU’s competitiveness”
The EU member states have agreed on a compromise for pharmaceutical legislation, which means, among other things, that the data protection period will remain unchanged at eight years.
